The cyclic octapeptide antibiotic argyrin B inhibits translation by trapping EF-G on the ribosome during translocation

Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2114214119. doi: 10.1073/pnas.2114214119. Epub 2022 May 2.

Abstract

Argyrins are a family of naturally produced octapeptides that display promising antimicrobial activity against Pseudomonas aeruginosa. Argyrin B (ArgB) has been shown to interact with an elongated form of the translation elongation factor G (EF-G), leading to the suggestion that argyrins inhibit protein synthesis by interfering with EF-G binding to the ribosome. Here, using a combination of cryo-electron microscopy (cryo-EM) and single-molecule fluorescence resonance energy transfer (smFRET), we demonstrate that rather than interfering with ribosome binding, ArgB rapidly and specifically binds EF-G on the ribosome to inhibit intermediate steps of the translocation mechanism. Our data support that ArgB inhibits conformational changes within EF-G after GTP hydrolysis required for translocation and factor dissociation, analogous to the mechanism of fusidic acid, a chemically distinct antibiotic that binds a different region of EF-G. These findings shed light on the mechanism of action of the argyrin-class antibiotics on protein synthesis as well as the nature and importance of rate-limiting, intramolecular conformational events within the EF-G-bound ribosome during late-steps of translocation.

Keywords: antibiotic; argyrin; fusidic acid; ribosome; translocation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / metabolism
  • Fusidic Acid / pharmacology
  • Humans
  • Oligopeptides
  • Peptide Elongation Factor G* / metabolism
  • Ribosomes / metabolism
  • Translocation, Genetic

Substances

  • Anti-Bacterial Agents
  • Oligopeptides
  • Peptide Elongation Factor G
  • argyrin B
  • Fusidic Acid